Rituximab Biosimilar N297A Research Grade,ichor.bio,ICH4011N297A
Detects human CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Rituximab.
Host
CHO Cells
Reactivity
Human
Platform ID
BAB951443761
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameRituximab Biosimilar N297A Research Grade
Cat. No.ICH4011N297A
Accession NumberP11836
HostCHO Cells
IsotypeHuman IgG1 (N297A)-Kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetCD20
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Rituximab is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab is produced by mammalian cell (Chinese Hamster Ovary).
Synonyms
MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7, membrane spanning 4-domains A1, FMC7
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.